Market Capitalization (Millions $) |
99 |
Shares
Outstanding (Millions) |
48 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-31 |
Cash Flow (TTM) (Millions $) |
-15 |
Capital Exp. (TTM) (Millions $) |
0 |
Cel Sci Corporation
Cel-Sci Corporation is a biotechnology company that focuses on the development of immunotherapy treatments for cancer and other diseases. The company's lead product, Multikine, is a potential immunotherapy treatment for head and neck cancer that is currently in late-stage clinical trials. Cel-Sci also has a platform technology called L.E.A.P.S. (Ligand Epitope Antigen Presentation System) that allows for the development of targeted immunotherapies for a variety of diseases. The company is headquartered in Vienna, Virginia, and is traded on the NYSE American exchange under the ticker symbol CVM.
Company Address: 8229 Boone Boulevard Vienna 22182 VA
Company Phone Number: 506-9460 Stock Exchange / Ticker: NYSEAMER CVM
|